SCHEMBL7401370

SCHEMBL7401370

NC(=O)c1ccccc1N1CCN(CCC2OCCc3ccccc32)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.61
DRD4 P21917 6/20 0.61
CA12 O43570 1/20 0.61
CA1 P00915 1/20 0.61
CA2 P00918 1/20 0.61
CA4 P22748 1/20 0.61
CA6 P23280 1/20 0.61
CA5A P35218 1/20 0.61
CA7 P43166 1/20 0.61
CA9 Q16790 1/20 0.61
CA13 Q8N1Q1 1/20 0.61
CA14 Q9ULX7 1/20 0.61
CA5B Q9Y2D0 1/20 0.61
HTR2A P28223 7/20 0.61
HTR1A P08908 6/20 0.61
ADRA2A P08913 1/20 0.61
ADRA2B P18089 1/20 0.61
ADRA2C P18825 1/20 0.61
DRD1 P21728 1/20 0.61
ADRA1D P25100 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7401366 1.00 DRD2 (0.61) DRD2DRD4CA12CA1CA2
SCHEMBL7400706 0.83 DRD2 (0.67) DRD2DRD4CA12CA1CA2
SCHEMBL5698979 0.83 DRD2 (0.73) DRD2DRD4CA12CA1CA2
SCHEMBL7397968 0.82 DRD2 (0.72) DRD2DRD4CA12CA1CA2
Hydrochloric Acid SCHEMBL8301019 0.82 DRD2 (0.65) DRD2DRD4CA12CA1CA2
SCHEMBL7401299 0.82 DRD2 (0.65) DRD2DRD4CA12CA1CA2
Hydrochloric Acid SCHEMBL8178893 0.82 DRD2 (0.72) DRD2DRD4CA12CA1CA2
SCHEMBL8593579 0.81 HTR1D (0.49) DRD2DRD4CA12CA1CA2
SCHEMBL8593593 0.81 HTR1D (0.49) DRD2DRD4CA12CA1CA2
Hydrochloric Acid SCHEMBL8179099 0.81 DRD2 (0.71) DRD2DRD4CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP claimed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP claimed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO claimed
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed